BackSorrento Therapeutics Overview

Sorrento Therapeutics Net Income

Profitability analysis for SRNE.

Quarterly Net Income

-$95.21M
↑ 56.63% YoY

As of Jun 2023

Annual Net Income (TTM)

-$534.20M
↓ 1.72% YoY

Trailing 12 months ending Jun 2023

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin